CRP and rheumatoid arthritis: Since remission or low disease activity is the goal of modern therapeutic treat-to-target approaches [34], it would be meaningful to explore the differences between κ/λ hybrid antibody, CRP, and ESR in discriminating low disease activity from moderate and high activity in RA.